A Novel CD19-directed Recombinant Bispecific Antibody Derivative With Enhanced Immune Effector Functions for Human Leukemic Cells

Title
A Novel CD19-directed Recombinant Bispecific Antibody Derivative With Enhanced Immune Effector Functions for Human Leukemic Cells
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOTHERAPY
Volume 31, Issue 9, Pages 871-884
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2008-10-16
DOI
10.1097/cji.0b013e318186c8b4

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started